And that is a reasonable general framework pulled from the clinical trial protocol
On the ground, the experiments were designed and executed by the students, Gler said
This new molecule, by acting synergistically on combined systems known to be altered in T2DM [33, 34], could indeed expand the therapeutic potential of GLP-1 agonists/analogues, suggesting new scenarios in terms of improving glycemic control, weight management, and hopefully providing protection against chronic micro-macrovascular complications and not only limited to hepatic complications
What has become increasingly clear since 2023 is that GLP-1 receptors are also active in areas of the brain involved in reward, impulse control, motivation, and stress regulation
RCT, randomized controlled trial
The Safety Profile Adverse events tracked the familiar GLP-1-class pattern, scaled up by dose